AlzeCure Pharma to present at Stora Aktiedagarna in Stockholm

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company’s CEO Martin Jönsson will present at Stora Aktiedagarna in Stockholm, hosted by Aktiespararna, at 08:50 CET on November 27.

During the day, Martin Jönsson will present the company's project portfolio and drug candidates within the three research platforms NeuroRestore®, Alzstatin® and Painless, including the lead candidate ACD856, which is being prepared for clinical phase 2 studies. The presentation will be followed by a Q&A led by Aktiespararna’s moderator.

The live broadcast is available via the following link:
Livesändning av Stora Aktiedagarna i Stockholm | Stora Aktiedagarna i Stockholm

The presentation will also be available on the company's website afterwards: https://www.alzecurepharma.se/en/presentations-and-interviews/.

For more information about the event and to register to attend the Birger Jarl Conference in Stockholm, please see here: Stora Aktiedagarna i Stockholm | Aktiespararna

Datum 2024-11-20, kl 10:00
Källa MFN
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet